
    
      Purpose To evaluate the effects of conventional treatment compared to use of Manuka Honey eye
      drops in the treatment of meibomian gland dysfunction related dry eye disease.

      Design Assessor-masked (Single blind, randomized controlled trial comparing the conventional
      treatment group to an interventional group using 16% Manuka Honey topical eye drops.

      Methods Patients were randomized into two groups, one group given conventional treatment for
      meibomian gland dysfunction. The other group was given additional manuka honey 16% eye drops
      which are registered as a medical device by the australian FDA. SPEED score was taken at
      baseline and upon follow up. Multiple parameters were graded from slit lamp examination by a
      masked assessor. Results were compared from baseline to follow up date 3 weeks later.
    
  